AHEAD INTERNATIONAL AND GERMAN STUDIES: 6-YEAR INTERIM EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH HEMOPHILIA A RECEIVING ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A REAL-WORLD SETTING
J. Oldenburg
(1)
,
M. C. Ozelo
(2)
,
R. Klamroth
(3)
,
B. Guillet
(4)
,
A. Huth-Kuehne
(5)
,
K. Kurnik
(6)
,
K. Khair
(7)
,
D. A. Tsakiris
(8)
,
J. Botha
(9)
,
A. Fernandez
(9)
,
S. Regensburger
(9)
,
L. Tang
(9)
,
E. Santagostino
(10)
1
UKB -
Universitätsklinikum Bonn
2 UNICAMP - Universidade Estadual de Campinas = University of Campinas
3 Vivantes Klinikum Friedrichshain
4 Irset - Institut de recherche en santé, environnement et travail
5 SRH Kurpfalzhospital
6 Klinikum der Universität [München]
7 GOSH - Great Ormond Street Hospital for Children [London]
8 University Hospital Basel [Basel]
9 Shire [Zug]
10 Fondazione Luigi Villa - Angelo Bianchi Bonomi Hemophilia and Thrombosis Center [Milan, Italy]
2 UNICAMP - Universidade Estadual de Campinas = University of Campinas
3 Vivantes Klinikum Friedrichshain
4 Irset - Institut de recherche en santé, environnement et travail
5 SRH Kurpfalzhospital
6 Klinikum der Universität [München]
7 GOSH - Great Ormond Street Hospital for Children [London]
8 University Hospital Basel [Basel]
9 Shire [Zug]
10 Fondazione Luigi Villa - Angelo Bianchi Bonomi Hemophilia and Thrombosis Center [Milan, Italy]